Skip to main content
Clinical Trials/NCT04072796
NCT04072796
Completed
Not Applicable

The Effects of Stroke Related Neurogenic Bladder on The Quality of Life: A Study of Turkish Population

Istanbul Physical Medicine Rehabilitation Training and Research Hospital1 site in 1 country71 target enrollmentStarted: January 15, 2015Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Enrollment
71
Locations
1
Primary Endpoint
Short Form-36 (SF-36)

Overview

Brief Summary

This study investigated effects of the neurogenic bladder on the quality of life in stroke survivors. Patients were divided into two groups: the First group consisted of patients with neurogenic bladder and the Second group consisted of patients without neurogenic bladder.

Detailed Description

Neurogenic bladder after stroke is a commonly encountered medical condition which slows down the recovery process and exacerbates the functional status of the patient. The neurogenic bladder may possibly affect the quality of life of patients with stroke.

Objectives: The aim of this study is to investigate the relationship between the quality of life and the neurogenic bladder in Turkish stroke survivors.

Methods: 71 patients with stroke were included in the study. Patients were divided into two groups: the First group consisted of patients with neurogenic bladder and the Second group consisted of patients without neurogenic bladder. Short Form-36 (SF-36), Barthel Index (BI), Functional Ambulation Category (FAC), Mini-Mental Test (MMT) and Beck Depression Inventory (BDI) questionnaires were applied to both groups for clinical evaluations.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
30 Years to 88 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hemorrhagic or ischemic stroke
  • No previous stroke history
  • Disease duration \> 6 months

Exclusion Criteria

  • Patients with different stroke etiologies other than cerebrovascular events (such as traumatic and tumoral pathologies)
  • Previous multiple stroke history
  • Pre-stroke urinary complaints
  • Previous urogenital surgery history
  • Spinal Cord Injury (SCI)
  • Prostate volume of \> 35ml documented with urinary ultrasonography
  • Bladder outlet obstruction
  • Poorly controlled Diabetes Mellitus (DM)
  • Concomitant neurological diseases such as Multiple Sclerosis and Parkinson's Disease
  • Anticholinergic, alpha agonist-antagonist drug use

Outcomes

Primary Outcomes

Short Form-36 (SF-36)

Time Frame: 15 minutes

Short Form-36 (SF-36) was used to evaluate the quality of life of the patients. The form consists of 36 items, which measure 8 dimensions. These include (1) Physical function, (2) Social function, (3) Pain, (4) Energy/vitality, (5) Role limitation due to emotional problems , (6) Role limitation due to physical health problems, (7) Mental health and (8) General perception of health. Each subscale is evaluated between 0-100 points. A higher score indicates the better health.

Secondary Outcomes

  • Functional Ambulation Category(15 minute)
  • Brunnstrom scale(15 minute)
  • Beck Depression Inventory(15 minutes)
  • Mini Mental Test (MMT)(15 minutes)
  • Barthel Index (BI)(15 minute)

Investigators

Sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials